Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Ranghetti

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Plos One|March 3, 2010
Gene expression profiles identify inflammatory signatures in dendritic cellsAnna Torri, Ottavio Beretta, Anna Ranghetti, et al.
International Journal of Systematic and Evolutionary Microbiology|July 24, 2009
Novel members of the family Micromonosporaceae, Rugosimonospora acidiphila gen. nov., sp. nov. and Rugosimonospora africana sp. novPaolo Monciardini, Linda Cavaletti, Anna Ranghetti, et al.
The British Journal of Ophthalmology|May 6, 2016
Angiopoietin 2 expression in the cornea and its control of corneal neovascularisationGiulio Ferrari, Chiara Giacomini, Fabio Bignami, et al.
Cell Reports|July 27, 2012
miR-511-3p modulates genetic programs of tumor-associated macrophagesMario Leonardo Squadrito, Ferdinando Pucci, Laura Magri, et al.
Cancer Cell|April 13, 2011
Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cellsRoberta Mazzieri, Ferdinando Pucci, Davide Moi, et al.
Science Translational Medicine|January 3, 2014
Genetic engineering of hematopoiesis for targeted IFN-α delivery inhibits breast cancer progressionGiulia Escobar, Davide Moi, Anna Ranghetti, et al.
Nature Communications|July 26, 2018
Interferon gene therapy reprograms the leukemia microenvironment inducing protective immunity to multiple tumor antigensGiulia Escobar, Luigi Barbarossa, Giulia Barbiera, et al.
Cancer Cell|June 15, 2016
miRNA-126 Orchestrates an Oncogenic Program in B Cell Precursor Acute Lymphoblastic LeukemiaSilvia Nucera, Alice Giustacchini, Francesco Boccalatte, et al.
Science Translational Medicine|July 20, 2022
Targeted inducible delivery of immunoactivating cytokines reprograms glioblastoma microenvironment and inhibits growth in mouse modelsFilippo Birocchi, Melania Cusimano, Federico Rossari, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Plos One|March 3, 2010
Gene expression profiles identify inflammatory signatures in dendritic cellsAnna Torri, Ottavio Beretta, Anna Ranghetti, et al.
International Journal of Systematic and Evolutionary Microbiology|July 24, 2009
Novel members of the family Micromonosporaceae, Rugosimonospora acidiphila gen. nov., sp. nov. and Rugosimonospora africana sp. novPaolo Monciardini, Linda Cavaletti, Anna Ranghetti, et al.
The British Journal of Ophthalmology|May 6, 2016
Angiopoietin 2 expression in the cornea and its control of corneal neovascularisationGiulio Ferrari, Chiara Giacomini, Fabio Bignami, et al.
Cell Reports|July 27, 2012
miR-511-3p modulates genetic programs of tumor-associated macrophagesMario Leonardo Squadrito, Ferdinando Pucci, Laura Magri, et al.
Cancer Cell|April 13, 2011
Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cellsRoberta Mazzieri, Ferdinando Pucci, Davide Moi, et al.
Science Translational Medicine|January 3, 2014
Genetic engineering of hematopoiesis for targeted IFN-α delivery inhibits breast cancer progressionGiulia Escobar, Davide Moi, Anna Ranghetti, et al.
Nature Communications|July 26, 2018
Interferon gene therapy reprograms the leukemia microenvironment inducing protective immunity to multiple tumor antigensGiulia Escobar, Luigi Barbarossa, Giulia Barbiera, et al.
Cancer Cell|June 15, 2016
miRNA-126 Orchestrates an Oncogenic Program in B Cell Precursor Acute Lymphoblastic LeukemiaSilvia Nucera, Alice Giustacchini, Francesco Boccalatte, et al.
Science Translational Medicine|July 20, 2022
Targeted inducible delivery of immunoactivating cytokines reprograms glioblastoma microenvironment and inhibits growth in mouse modelsFilippo Birocchi, Melania Cusimano, Federico Rossari, et al.
Pageof 1